Cathay Biotech Inc.
Research Cathay Biotech Inc. (688065.SS) on Bullrun: market cap CNY 28.21B, P/E 44.4, dividend yield 1.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker688065.SS
- ExchangeSS
- CountryChina
- SectorBasic Materials
- IndustryChemicals
- CurrencyCNY
- Market capCNY 28.21B
- P/E44.4
- Dividend yield1.2%
- Financial periodQ2 2026
- RevenueCNY 1.03B
- Net incomeCNY 207.01M
- Free cash flowCNY 514.90M
- Gross margin35.5%
Valuation Snapshot
latest market cap is CNY 28.21B; P/E is 44.4; dividend yield is 1.2%.
Peer valuation comparison
Latest P/E is 44.44x versus a Basic Materials sector median of 14.77x (200.8% above).
Latest dividend yield is 1.15% versus a Basic Materials sector median of 2.67% (56.9% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-11 | CNY 28.21B | 44.4 | 1.3% | 0.45 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.45 CNY, yield 1.2%.
About Cathay Biotech Inc.
Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for electrification, automation, and digitization for biological manufacturing.
ETFs that hold Cathay Biotech Inc.
US-listed ETFs
Cathay Biotech Inc. is held by 20 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU) | <0.01% | 0.04% |
| Schwab Emerging Markets Equity ETF (SCHE) | <0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Basic Materials stocks
Frequently asked questions
What is Cathay Biotech Inc.'s market cap?
Cathay Biotech Inc.'s market capitalization is CNY 28.21B.
What is Cathay Biotech Inc.'s P/E ratio?
Cathay Biotech Inc.'s price-to-earnings (P/E) ratio is 44.4.
Does Cathay Biotech Inc. pay a dividend?
Cathay Biotech Inc. has a dividend yield of 1.2%.
What does Cathay Biotech Inc. do?
Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for electrification, automation, and digitization for biological manufacturing.